Yi‐Jou Tai

786 total citations
35 papers, 561 citations indexed

About

Yi‐Jou Tai is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Yi‐Jou Tai has authored 35 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 13 papers in Obstetrics and Gynecology and 9 papers in Oncology. Recurrent topics in Yi‐Jou Tai's work include Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cervical Cancer and HPV Research (6 papers). Yi‐Jou Tai is often cited by papers focused on Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (9 papers) and Cervical Cancer and HPV Research (6 papers). Yi‐Jou Tai collaborates with scholars based in Taiwan, South Korea and Ireland. Yi‐Jou Tai's co-authors include Wen‐Fang Cheng, Ying‐Cheng Chiang, Qi Zhang, Yu‐Li Chen, Chi‐An Chen, Heng‐Cheng Hsu, Chi-Fang Chang, Han-Wei Lin, Chun‐Pin Chiang and Andy Sun and has published in prestigious journals such as PLoS ONE, The Journal of Physical Chemistry B and Scientific Reports.

In The Last Decade

Yi‐Jou Tai

31 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Jou Tai Taiwan 11 260 210 133 65 62 35 561
Kawaljit Kaur United States 18 464 1.8× 572 2.7× 143 1.1× 61 0.9× 25 0.4× 59 945
Micaela Morgado United States 9 366 1.4× 252 1.2× 169 1.3× 84 1.3× 30 0.5× 12 641
Abigail L. Sedlacek United States 11 191 0.7× 268 1.3× 111 0.8× 28 0.4× 58 0.9× 18 477
Marko Määttã Finland 17 94 0.4× 67 0.3× 202 1.5× 131 2.0× 17 0.3× 28 835
Alexander Marmé Germany 14 281 1.1× 416 2.0× 338 2.5× 102 1.6× 63 1.0× 22 914
Laureano Simón Spain 13 113 0.4× 163 0.8× 207 1.6× 58 0.9× 109 1.8× 29 660
Kurosh Rahimi Canada 17 384 1.5× 298 1.4× 312 2.3× 138 2.1× 271 4.4× 46 1.0k
Biancamaria Ricci Italy 16 306 1.2× 493 2.3× 420 3.2× 110 1.7× 26 0.4× 26 962
Yuh-Cheng Yang Taiwan 12 156 0.6× 165 0.8× 141 1.1× 50 0.8× 104 1.7× 18 576
S. Staibano Italy 13 174 0.7× 54 0.3× 339 2.5× 66 1.0× 19 0.3× 25 548

Countries citing papers authored by Yi‐Jou Tai

Since Specialization
Citations

This map shows the geographic impact of Yi‐Jou Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Jou Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Jou Tai more than expected).

Fields of papers citing papers by Yi‐Jou Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Jou Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Jou Tai. The network helps show where Yi‐Jou Tai may publish in the future.

Co-authorship network of co-authors of Yi‐Jou Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Jou Tai. A scholar is included among the top collaborators of Yi‐Jou Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Jou Tai. Yi‐Jou Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tai, Yi‐Jou, et al.. (2025). Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort study. Gynecologic Oncology Reports. 59. 101732–101732.
2.
Tai, Yi‐Jou, et al.. (2025). Self‐Healable Hydrogel for Regression of Liver Fibrosis. Biotechnology and Bioengineering. 122(6). 1496–1511.
3.
Wu, Mei-Hsuan, et al.. (2025). Risk factors of recurrent cervical intraepithelial neoplasm 2/3 after primary excisional conization/LEEP treatments: A follow-up nationwide cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology X. 26. 100397–100397.
4.
Chiang, Chun‐Ju, Yi‐Jou Tai, Heng‐Cheng Hsu, et al.. (2024). Outcomes after fertility‐sparing surgery of early‐stage ovarian cancer: A nationwide population‐based study. Cancer Medicine. 13(7). e7132–e7132. 2 indexed citations
5.
Tai, Yi‐Jou, et al.. (2023). Nontuberculous mycobacterial infection mimicking gynecologic malignancy in a woman living with HIV. International Journal of Infectious Diseases. 137. 25–27. 1 indexed citations
6.
Tai, Yi‐Jou, et al.. (2023). Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers. Scientific Reports. 13(1). 3 indexed citations
7.
Chen, Jenny Ling‐Yu, Chao‐Yuan Huang, I‐Lun Shih, et al.. (2023). Prognostic nutritional index and neutrophil-lymphocyte ratio predict toxicities and prognosis in patients with cervical cancer treated with curative radiochemotherapy. Journal of the Formosan Medical Association. 123(6). 671–678. 12 indexed citations
8.
Tai, Yi‐Jou, et al.. (2022). Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patients.. PubMed. 12(9). 4211–4226. 2 indexed citations
9.
Hsu, Heng‐Cheng, et al.. (2021). Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors. Frontiers in Oncology. 11. 694441–694441. 4 indexed citations
10.
Tai, Yi‐Jou, et al.. (2020). Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients. Journal of Gynecologic Oncology. 32(2). e18–e18. 9 indexed citations
11.
Hsu, Heng‐Cheng, Yi‐Jou Tai, Yu‐Li Chen, et al.. (2019). Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies. Frontiers in Pharmacology. 10. 426–426. 19 indexed citations
12.
Hsu, Heng‐Cheng, Yi‐Jou Tai, Yu‐Li Chen, et al.. (2018). Factors predicting parametrial invasion in patients with early-stage cervical carcinomas. PLoS ONE. 13(10). e0204950–e0204950. 13 indexed citations
13.
Chen, Yu‐Li, Han-Wei Lin, Ying‐Cheng Chiang, et al.. (2018). Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes. Cancer Letters. 444. 20–34. 16 indexed citations
14.
Tai, Yi‐Jou, Heng‐Cheng Hsu, Ying‐Cheng Chiang, et al.. (2017). Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies. Frontiers in Pharmacology. 8. 800–800. 11 indexed citations
15.
Tai, Yi‐Jou, Chun‐Ju Chiang, San‐Lin You, et al.. (2017). Clinical management and risk reduction in women with low-grade squamous intraepithelial lesion cytology: A population-based cohort study. PLoS ONE. 12(12). e0188203–e0188203. 11 indexed citations
16.
Tai, Yi‐Jou, et al.. (2016). Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation. Oncogenesis. 5(2). e198–e198. 225 indexed citations
17.
Tai, Yi‐Jou, et al.. (2014). Solitary primary peritoneal carcinoma arising from the omentum. Taiwanese Journal of Obstetrics and Gynecology. 53(2). 256–259.
18.
Tai, Yi‐Jou, et al.. (2014). Ovarian steroid cell tumor, not otherwise specified, with virilization symptoms. Taiwanese Journal of Obstetrics and Gynecology. 53(2). 260–262. 4 indexed citations
19.
Tai, Yi‐Jou & Susan Shur‐Fen Gau. (2012). Trends in the prevalence of developmental disabilities in Taiwan youngsters, 1997–2009. Neuropsychiatrie de l Enfance et de l Adolescence. 60(5). S216–S216. 1 indexed citations
20.
Tai, Yi‐Jou. (2003). Stem cells as a potential treatment of neurological disorders. Current Opinion in Pharmacology. 4(1). 98–104. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kawaljit Kaur Breakdown of academic impact, for papers by Micaela Morgado Breakdown of academic impact, for papers by Abigail L. Sedlacek Breakdown of academic impact, for papers by Marko Määttã Breakdown of academic impact, for papers by Alexander Marmé Breakdown of academic impact, for papers by Laureano Simón Breakdown of academic impact, for papers by Kurosh Rahimi Breakdown of academic impact, for papers by Biancamaria Ricci Breakdown of academic impact, for papers by Yuh-Cheng Yang Breakdown of academic impact, for papers by S. Staibano
Rankless by CCL
2026